Merck has signed a landmark voluntary licensing deal with the UN-backed Medicines Patent Pool to expand low-cost access to its Covid-19 antiviral pill throughout the developing world.
默克(Merk)与联合国(UN)支持的“药物专利池”(Medicines Patent Pool)签署了一项具有里程碑意义的自愿许可协议，以扩大其新冠抗病毒药物在整个发展manbetx3.0 家的低成本获取。
您已阅读6%（278字），剩余94%（4364字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。